Therapeutic Areas
Primary Point of Contact
Associate Director – Statistical Programming
14+ years of industry experience
Therapeutic areas: Oncology, CNS, CV, Rare Diseases
Regulatory exposure: FDA, EMA, PMDA
Expertise: SAS, R, Python, CDISC, Automation
Escalation Structure
Study-level leadership
Program-level oversight
Executive steering support
CENTRAL NERVOUS SYSTEM
At Sigma-Chi, we share your deep commitment to developing therapies to alleviate these conditions. Yet the challenges of CNS diseases bring associated challenges to conducting clinical trials. Cognitive impairment, memory loss, reduced movement and sensory capabilities – these create a high burden of disease on patients as well as the caregivers on whom many are dependent.
DERMATOLOGY
To be most successful, dermatology clinical trials should be accessible to a diverse array of qualified patients and designed to encourage patient participation. These trials should also reduce the patient and investigator site burdens, reduce start-up and enrollment timelines, and ensure consistent, high-quality assessments and data collection. With extensive experience in dermatology trials; an international network of sites with dermatology experience in key indications, such as psoriasis and atopic dermatitis; access to a large database of potential trial participants; and a commitment to tailored trial design and leveraging digital tools..
INFECTIOUS DISEASE AND VACCINE
Access our global infectious disease and vaccine experience to fight emerging and re-emerging diseases.
Sigma-Chi is ready to partner with you to conduct trials for infectious diseases caused by viruses, bacteria, fungi, or parasites. We’ve been part of the effort against COVID-19, and our extensive experience
provides a significant advantage in proven strategic planning, regulatory guidance, and successful clinical trial execution.
ONCOLOGY AND HEMATOLOGY
Small and mid-sized companies need the right partner.
Oncology remains the therapeutic area with the lowest success rate in clinical trials, underscoring the need for innovative approaches and a partner with deep experience in this fast-evolving, complex field.
